A randomized trial of bariatric surgery for the treatment of sleep apnea

一项减肥手术治疗睡眠呼吸暂停的随机试验

• 批准号: 8123379
• 负责人: Sanjay R Patel
• 金额: $ 60.05万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-14 至 2013-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8123379
• 关键词: randomized; trial; bariatric; surgery; treatment

DESCRIPTION (provided by applicant): Obstructive sleep apnea (OSA) is one of the most common complications of obesity, resulting in excessive sleepiness and daytime functional impairment. In addition, the recurrent exposure to intermittent hypoxemia appears to act synergistically with obesity in predisposing to hypertension, insulin resistance, diabetes, cardiovascular disease, and stroke. The current first line treatment for moderate to severe OSA, nasal continuous positive airway pressure (CPAP) is extremely effective but is often not well tolerated, leading to low adherence rates in many patients. Bariatric surgery has been approved as treatment for OSA in patients with co-morbid obesity and in small case series, appears to produce substantial improvements. However, no trials directly comparing bariatric procedures with standard CPAP treatment yet exist to guide clinicians and patients in choosing the most appropriate first line treatment. We propose to conduct a pilot study to address the feasibility and safety, and estimate the effect sizes for a subsequent Phase 3 trial. We will recruit 80 patients with severe OSA and morbid obesity (body mass index, BMI, of 35-40 kg/m2) from two large clinical sleep programs that together care for a wide spectrum and demographically diverse group of OSA patients. After establishing patient and physician equipoise, subjects will be randomized to a trial of CPAP or laparoscopic gastric banding as first line treatment for OSA. The primary outcome measures will be improvement in OSA severity under both ideal and real life conditions (i.e., in the OSA arm, while using CPAP in a controlled environment vs. while using prescribed therapy in the usual home environment, respectively), which will allow for assessments of both comparative efficacy and effectiveness. Outcomes will be assessed at 9 months to quantify the early effectiveness of each treatment strategy as well as to demonstrate clinical equipoise in conducting a future larger long term trial using these two arms. Further follow-up will occur at 18 months in a subset of 40 patients to determine effect sizes for the subsequent study at a point where the bariatric arm has neared a plateau in weight. Secondary outcomes will include patient-related outcomes including sleepiness, quality of life, and an index of health service utilization. In addition, changes in biomarkers related to inflammation, insulin resistance, lipids, blood pressure, and arterial stiffness will be assessed in each group, and in relationship to changes in BMI and OSA, to identify promising outcome measures for future trials. Incurred costs will be collected in all subjects in order to establish the parameters needed for a cost effectiveness analysis. This pilot study will represent the first controlled comparison of medical and surgical treatments for OSA and in addition, will provide the necessary data to develop the optimal study design for a subsequent long term multi-center comparative effectiveness study to better understand the potential role that bariatric surgery may offer in the management of OSA. PUBLIC HEALTH RELEVANCE: Sleep apnea, which involves breathing stoppages during sleep, is one of the most common complications of obesity. Currently the most common treatment for sleep apnea is continuous positive airway pressure (CPAP) which consists of a mask applied to the nose and a blower that blows air under pressure. While CPAP is effective at keeping the throat open, it is often uncomfortable and so difficult for many patients to use on a regular basis. Bariatric or weight loss surgery has been shown to be effective at producing weight loss and because of this, may also be effective at curing sleep apnea. In this study, we will conduct a trial comparing the ability of CPAP and bariatric surgery to treat sleep apnea in patients who have severe sleep apnea and morbid obesity.

描述（由申请人提供）：阻塞性睡眠呼吸暂停（OSA）是肥胖症最常见的并发症之一，导致过度嗜睡和日间功能障碍。此外，反复暴露于间歇性低氧血症似乎与肥胖协同作用，易患高血压、胰岛素抵抗、糖尿病、心血管疾病和中风。目前用于中度至重度OSA的一线治疗，经鼻持续气道正压通气（CPAP）非常有效，但通常耐受性不佳，导致许多患者的依从率较低。减肥手术已被批准用于治疗合并肥胖症的OSA患者，在小病例系列中，似乎产生了实质性的改善。然而，还没有直接比较减肥手术与标准CPAP治疗的试验来指导临床医生和患者选择最合适的一线治疗。我们建议进行一项试点研究，以解决可行性和安全性，并估计后续3期试验的效应量。我们将从两个大型临床睡眠项目中招募80名重度OSA和病态肥胖（体重指数，BMI，35-40 kg/m2）患者，这两个项目共同护理广泛的OSA患者人群。在建立患者和医生平衡后，受试者将被随机分配至CPAP或腹腔镜胃束带试验，作为OSA的一线治疗。主要结果测量将是在理想和真实的生活条件下OSA严重程度的改善（即，在OSA组中，分别在受控环境中使用CPAP时与在通常的家庭环境中使用处方治疗时），这将允许评估比较功效和有效性。将在9个月时评估结局，以量化每种治疗策略的早期有效性，并证明在使用这两组进行未来更大规模的长期试验时的临床平衡。将在18个月时对40名患者的子集进行进一步随访，以确定在减肥组体重接近稳定期时后续研究的效应大小。次要结局将包括患者相关结局，包括嗜睡、生活质量和卫生服务利用指数。此外，将评估各组中与炎症、胰岛素抵抗、血脂、血压和动脉僵硬度相关的生物标志物的变化，以及与BMI和OSA变化的关系，以确定未来试验的有希望的结局指标。将收集所有受试者的实际成本，以确定成本效益分析所需的参数。这项试点研究将代表OSA的药物和手术治疗的第一个对照比较，此外，将提供必要的数据，以开发最佳的研究设计，为随后的长期多中心比较有效性研究，以更好地了解减肥手术可能提供的潜在作用，在OSA的管理。 公共卫生相关性：睡眠呼吸暂停，涉及睡眠期间呼吸停止，是肥胖症最常见的并发症之一。目前，睡眠呼吸暂停最常见的治疗方法是持续气道正压通气（CPAP），它由一个面罩和一个鼓风机组成，面罩戴在鼻子上，鼓风机在压力下吹空气。虽然CPAP可以有效地保持喉咙开放，但它通常不舒服，并且对许多患者来说很难定期使用。减肥或减肥手术已被证明是有效的，在生产减肥，因为这一点，也可能是有效的治疗睡眠呼吸暂停。在这项研究中，我们将进行一项试验，比较CPAP和减肥手术治疗严重睡眠呼吸暂停和病态肥胖患者的睡眠呼吸暂停的能力。